Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC Should Send Warning Letters For Potentially Misleading Claims – Petition

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission should use warning letters when contested health benefit claims are "at worst, only potentially misleading," according to a petition for rulemaking submitted to FTC April 15

You may also be interested in...

Advisory Opinions On Supplement Ad Claims Infeasible, FTC Finds

Providing companies with advisory opinions clarifying Federal Trade Commission positions on "competent and reliable scientific evidence" standards for dietary supplement ad claims may not be feasible due to human resource concerns and previous rulings, the commission states.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts